J Milara, G Hernandez, B Ballester, A Morell, I Roger… - Respiratory …, 2018 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is the most rapidly progressive and fatal fibrotic disorder, with no curative therapies. The signal transducer and activator of …
I Roger, J Milara, P Montero, J Cortijo - International journal of molecular …, 2021 - mdpi.com
Pulmonary hypertension is defined as a group of diseases characterized by a progressive increase in pulmonary vascular resistance (PVR), which leads to right ventricular failure and …
J Liu, F Wang, F Luo - Biomolecules, 2023 - mdpi.com
There are four members of the JAK family and seven of the STAT family in mammals. The JAK/STAT molecular pathway could be activated by broad hormones, cytokines, growth …
L Yew-Booth, MA Birrell, MS Lau… - European …, 2015 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is an inflammatory disease of the lung, most commonly resulting from cigarette smoke exposure, characterised by a largely irreversible …
S Wang, M Liu, X Li, J Zhang, F Wang… - The FASEB …, 2022 - Wiley Online Library
Idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) are two fibrotic interstitial lung diseases that share the usual interstitial …
P Xin, X Xu, C Deng, S Liu, Y Wang, X Zhou… - International …, 2020 - Elsevier
The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell …
Q Hu, Q Bian, D Rong, L Wang, J Song… - … in Bioengineering and …, 2023 - frontiersin.org
Janus kinase/signal transduction and transcription activation (JAK/STAT) pathways were originally thought to be intracellular signaling pathways that mediate cytokine signals in …
Q Gao, X Liang, AS Shaikh, J Zang, W Xu… - Current Drug …, 2018 - ingentaconnect.com
Background: JAK/STAT signal pathway, a requisite part in the signaling process of growth factors and cytokines, has become attractive targets for numerous immune, inflammatory …
J Milara, B Ballester, A Morell, JL Ortiz, J Escrivá… - Thorax, 2018 - thorax.bmj.com
Background Pulmonary hypertension (PH) is a common disorder in patients with idiopathic pulmonary fibrosis (IPF) and portends a poor prognosis. Recent studies using vasodilators …